Ticagrelor and Prasugrel: Two Novel, Most-Promising Antiplatelet Agents

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|5|3|208-211

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.5, Iss.3, 2010-11, pp. : 208-211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prasugrel: A Novel Antiplatelet Therapy for Acute Coronary Syndromes

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 3, 2009-11 ,pp. : 192-202

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance to high-maintenance dose of prasugrel treated by ticagrelor: A case report

By Xanthopoulou Ioanna  

Platelets, Vol. 24, Iss. 3, 2013-05 ,pp. : 239-241

Informa Healthcare

Access to resources Recommend Favorite

Current Problems, New Opportunities and Future Directions of Antiplatelet Therapy - Increasing Role of Novel Antiplatelet Agents in Cardiovascular Diseases

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 55-60

Bentham Science Publishers

Access to resources Recommend Favorite

Ticagrelor: A Novel Drug for an Old Problem

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Iss. 1, 2014-06 ,pp. : 51-57

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet agents in cardiovascular disease

By Lopes Renato  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 306-309

Springer Publishing Company

Access to resources Recommend Favorite